Cooper Companies (NYSE:COO)‘s stock had its “buy” rating restated by stock analysts at Raymond James Financial in a research note issued on Monday. They currently have a $265.00 price objective on the medical device company’s stock. Raymond James Financial’s price objective suggests a potential upside of 14.28% from the stock’s current price.

Several other equities analysts have also weighed in on COO. Zacks Investment Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday, August 14th. Jefferies Group set a $250.00 price objective on shares of Cooper Companies and gave the company a “buy” rating in a report on Thursday, August 17th. Cleveland Research reiterated a “buy” rating on shares of Cooper Companies in a report on Tuesday, August 22nd. Robert W. Baird reiterated a “buy” rating and set a $251.00 price objective on shares of Cooper Companies in a report on Thursday, August 24th. Finally, KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a report on Monday, August 28th. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Cooper Companies presently has an average rating of “Buy” and a consensus target price of $260.70.

Cooper Companies (COO) opened at $231.89 on Monday. Cooper Companies has a fifty-two week low of $162.94 and a fifty-two week high of $256.39. The firm has a market cap of $11,250.00, a PE ratio of 25.47, a PEG ratio of 2.02 and a beta of 0.54. The company has a current ratio of 2.51, a quick ratio of 1.29 and a debt-to-equity ratio of 0.38.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.60% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. ProVise Management Group LLC grew its position in Cooper Companies by 0.6% in the 2nd quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock worth $282,000 after purchasing an additional 7 shares in the last quarter. YorkBridge Wealth Partners LLC grew its position in Cooper Companies by 2.1% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after purchasing an additional 11 shares in the last quarter. CIBC Asset Management Inc grew its position in Cooper Companies by 0.3% in the 2nd quarter. CIBC Asset Management Inc now owns 4,697 shares of the medical device company’s stock worth $1,125,000 after purchasing an additional 16 shares in the last quarter. Wedbush Securities Inc. grew its position in Cooper Companies by 1.0% in the 2nd quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock worth $427,000 after purchasing an additional 18 shares in the last quarter. Finally, Sentry Investment Management LLC grew its position in Cooper Companies by 0.7% in the 2nd quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock worth $671,000 after purchasing an additional 19 shares in the last quarter. 96.79% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Cooper Companies (COO) Stock Rating Reaffirmed by Raymond James Financial” was posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.watchlistnews.com/cooper-companies-coo-stock-rating-reaffirmed-by-raymond-james-financial/1746402.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.